Tamarly Intelligence
Deal · Completed

Lisata Therapeutics, Inc. and Marea pursuant

First filed 17 Sept 2026, 1 filing.

The deal
Buyer
Lisata Therapeutics, Inc.
Target
Marea pursuant
Status
Completed
Region
US
On September 17, 2026, the Company completed its acquisition of Marea pursuant to the Merger Agreement. The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.

Source: The filing (SEC Form 8-K)

With a free account

A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.